CDC Director Robert R. Redfield, MD, does not mince words in the CDC’s antibiotic threat report: “You and I are living in a time when some miracle drugs no longer perform miracles and families are being ripped apart by a microscopic enemy. The time for action is now and we can be part of the solution.”
The CDC, along with other national and local partners, is tackling antimicrobial resistance from multiple angles, including infection prevention and investing in vaccines and new therapeutics. Antimicrobial stewardship—an effort to optimize the use of antimicrobials—is another key front in the battle against antimicrobial resistance.
Syndromic infectious disease diagnostics from BioFire can aid in antimicrobial stewardship efforts with fast, accurate, and comprehensive testing.2 Rapid answers on a comprehensive menu of pathogens and antibiotic resistance markers can enable physicians to optimize patient therapy quickly, avoiding unnecessary antimicrobials.
For example, patients tested with the BioFire® FilmArray® Gastrointestinal Panel were less likely to be prescribed antibiotics,3 and patients were more likely to be prescribed targeted therapy compared to traditional testing.4